Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18. Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. Case and Commentary Feb 2021 Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención Saul J. Weiner, MD AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Case and Commentary Dec 2021 Whose Responsibility Is It to Address Bullying in Health Care? Lindsey E. Carlasare, MBA and Gerald B. Hickson, MD A culture of safety and respect in sites of health care education and work is foundational to the well-being of everyone in health care. AMA J Ethics. 2021;23(12):E931-936. doi: 10.1001/amajethics.2021.931. Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18.
Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.
Case and Commentary Feb 2021 Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención Saul J. Weiner, MD AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Case and Commentary Dec 2021 Whose Responsibility Is It to Address Bullying in Health Care? Lindsey E. Carlasare, MBA and Gerald B. Hickson, MD A culture of safety and respect in sites of health care education and work is foundational to the well-being of everyone in health care. AMA J Ethics. 2021;23(12):E931-936. doi: 10.1001/amajethics.2021.931.
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.
Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.